Is divalproex a cost-effective alternative in the acute and prophylactic treatment of bipolar I disorder?
Dardennes
R M
RM
Even
C
C
D000208:Acute Disease; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000517:prevention & control* / Q000523:psychology; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017048:Health Care Costs; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D008094:Lithium / Q000191:economics / Q000627:therapeutic use; D012107:Research Design; D016896:Treatment Outcome; D014635:Valproic Acid / Q000191:economics* / Q000627:therapeutic use*
D014635:Valproic Acid; D008094:Lithium